The pros and cons of interferons for oncolytic virotherapyKaren Geoffroy(Université de Montréal), Marie‐Claude Bourgeois‐Daigneault(Université de Montréal)Cytokine & Growth Factor ReviewsJuly 3, 202010.1016/j.cytogfr.2020.07.002Cited by 28SaveCiteExport RISWatch citationsAbstractRelated PapersCutting Edge: Cross-Talk Between Cells of the Innate Immune System: NKT Cells Rapidly Activate NK CellsClaude Carnaud, Daniel Lee, Olivier Donnars et al.|The Journal of Immunology|1999|851Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.Thomas F. Gajewski, F W Fitch|The Journal of Immunology|1988|838Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virusDavid F. Stojdl, Brian D. Lichty, Shane Knowles et al.|Nature Medicine|2000|816Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase.Y. Yang, Luiz F. L. Reis, Jovan Pavlovic et al.|The EMBO Journal|1995|632Quantitative studies on viral interference in suspended L cellsKurt Paucker, Kari Cantell, Werner Henle|Virology|1962|392